Study found no birth defect risk from tetracycline use during first trimester of pregnancy
On Nov. 15, 2024, a team led by researchers from Sweden’s Karolinska Institutet reported study results that showed…
Nasal Swab Tests Predict COVID-19 Disease Severity, Study Finds
On Nov. 6, 2024, researchers from Emory University, in collaboration with scientists at Gladstone Institutes and University of…
CDC reported little to no immunity to H5N1 avian flu virus in Americans
On Jun. 14, 2024 the Centers for Disease Control and Prevention (CDC) reported data from this study suggested…
Study suggested staying current with COVID-19 vaccinations helped combat emerging variants
On Apr. 12, 2024, Oregon Health Sciences University (OHSU) announced research that shows using live SARS-CoV-2 virus revealed…
New antibodies target ‘Dark Side’ of influenza virus protein
On Mar. 1, 2024, researchers at the National Institutes of Health (NIH) announced they had identified antibodies targeting…
Biotechnology | COVID-19 | FDA | Vaccine
Moderna clinical trial data confirmed updated Covid-19 vaccine generated strong immune response against BA.2.86 variant
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
COVID-19 vaccination and boosting during pregnancy benefits pregnant women and newborns
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
University of Illinois Urbana-Champaign team developed all-species coronavirus test
On Jul. 6, 2023, University of Illinois Urbana-Champaign researchers reported they can detect exposure to the SARS-CoV-2 virus…
Biotechnology | Diagnostics | Disease | FDA | Rare Disease | Therapeutics
U.S. FDA approved BioMarin’s ROCTAVIAN, the first and only gene therapy for adults with severe hemophilia A
On Jun. 29, 2023, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy…
Study raised concerns SARS-CoV-2 evolution outpaces vaccine-generated antibodies
On Apr. 27, 2023, a NIAID-led Phase 2 trial compared two Pfizer bivalent mRNA COVID-19 boosters found that…
Antibiotics do not cut death risk in hospitalized patients with viral respiratory illnesses
On Mar. 24. 2023, antibiotics do not reduce the risk of dying in adults hospitalized with COVID-19, the…
First gene therapy for adults with severe hemophilia A, BioMarin’s ROCTAVIAN, approved by EC
On Aug. 24, 2022, BioMarin Pharmaceutical announced that the European Commission (EC) had granted conditional marketing authorization (CMA)…
Vaccine-induced immune response to Omicron wanes substantially over time
On Jul. 19, 2022, the NIH announced that although COVID-19 booster vaccinations in adults elicit high levels of…
COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses
On Jul. 5, 2022, Tgen and Northern Arizona University announced that a research team found that the vaccine…
NIH study revealed how immune response triggered by COVID-19 may damage the brain
On Jul. 5, 2022, the National Institutes of Health released a study that described the immune response triggered…
IAVI and Moderna partnered to tackle broad global health priorities using mRNA for vaccines and antibodies
On Apr. 7, 2022, Moderna and IAVI announced a collaboration to employ mRNA technology to meet the challenge…
Scientists pinpointed mechanisms associated with severe COVID-19 blood clotting
On Feb. 17, 2022, after studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers,…
WHO and Viamo provided critical access to COVID-19 information to the next billion digital users via their mobile phones
On Jan. 28, 2022, the WHO announced that COVID-19 information had reached 1,292,209 people through Viamoﾒs 3-2-1 Platform…
Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19
On Jan. 27, 2022, NIAID announced that a clinical trial found that the combination of remdesivir plus a…
University of Missouri researchers identified mutations of Delta, Delta Plus variants
On Jan. 25, 2022, researchers at the University of Missouri announced they had identified the highly prevalent, specific…
Pfizer and BioNTech published data from two studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant
On Jan. 24, 2022, Pfizer and BioNTech announced the publication of new results from two laboratory studies demonstrating…
Biotechnology | COVID-19 | NIH | Therapeutics
‘Ultrapotent’ antibodies neutralized SARS-CoV-2 variants in NIAID study
On Jan. 20, 2022, scientists from the National Institute of Allergy and Infectious Diseases (NIAID) announced that they…
Pfizer and BioNTech provided update on Omicron variant
On Dec. 8, 2021, Pfizer and BioNTech announced results from an initial laboratory study demonstrating that serum antibodies…
Llama antibodies could help fight SARS-CoV-2 variants
On Dec. 7, 2021, Rockefeller University scientists announced a study had demonstrated the therapeutic potential of an unusual…
WHO and Medicines Patent Pool announced first transparent, global, non-exclusive licence for COVID-19 technology
On Nov. 23, 2021, the World Health Organization’s COVID-19 Technology Access Pool and the Medicines Patent Pool finalized…
Fulgent Genetics launched at-home neutralizing antibody test for COVID-19
On Oct. 27, 2021, Fulgent Genetics announced that it had launched an antibody test for COVID-19 which specifically…
COVID-19 booster increased antibody responses, was protective in rhesus macaques
On Oct. 21, 2021, the National Institutes of Health announced that a booster dose of the mRNA-1273 COVID-19…
COVID-19 | Diagnostics | FDA
EUROIMMUN anti-SARS-CoV-2 S1 curve ELISA received FDA Emergency Use Authorization
On Oct. 5, 2021, PerkinElmer announced that the U.S. Food and Drug Administration had provided Emergency Use Authorization…
US Department of Defense awarded $3.2 billion in contract modifications for monoclonal antibodies
On Sept. 15, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
Biotechnology | COVID-19 | Diagnostics | FDA
InBios received FDA EUA for COVID-19 IgG antibody rapid test
On Sept. 15, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…